Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

NINDS grant supports Sinopia's IND-enabling studies of Parkinson's candidate

Sep. 28, 2021

Hanyang University discovers MAPK10 inhibitors

Sep. 28, 2021

Infection derails healing after brain injury

Sep. 27, 2021

Avicanna's novel cannabinoid formulation shows promising preclinical results for epilepsy

Sep. 27, 2021

Ventus outlines NLRP3 inhibitor program

Sep. 27, 2021

Perampanel ameliorates development of alpha-syn pathology in models of PD

Sep. 27, 2021

SB-0107 shows antiparkinsonian activity in animal models

Sep. 27, 2021

LY-487379 shows synergistic effect on low-dose L-DOPA in a marmoset model

Sep. 27, 2021

Supera-CBD has superior potency over plant-derived CBD by factor of 8,000 times

Sep. 23, 2021

Mydecine reports preclinical data supporting MYCO-003 for anxiety and PTSD

Sep. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...